武田制药 TAK
$21.02 −$0.17 (-0.80%)
休市 · Nov 7, 10:10 pm ET · 最新盘后价 $21.74 +3.43%
开盘$20.62
昨收$21.19
当日区间$20.57 – $21.09
成交量2.97M
市值$67.36B
市盈率（TTM）296.1
股息率1.49%
TAK 相关新闻
匹配 Takeda Pharmaceutical 或代码 TAK 的头条新闻，按最新排序。
- OCEAN STAR TECH: PROXY FORM FOR USE AT THE ANNUAL GENERAL MEETING (THE "AGM")TO BE HELD AT 10:30 A.M. ON MONDAY, 28 SEPTEMBER 2026 AT ROOM 1606D&E, 16/F., KAI TAK COMMERCIALBUILDING, 317-319 DES VOEUX ROAD CENTRAL, SHEUNG WAN, HONG KONG (OR ANY ADJOURNMENT THEREOF)
- [Hong Kong Property] A four-bedroom unit at The Crown Kai Tak was sold for HK$169 million, translating to a price of HK$79,073 per square foot, setting new records for both transaction price and unit price among standard layouts.
- Společnosti Sceye a SoftBank Corp. Dokončily V Japonsku Demonstraci Stratosférického Připojení a Posunuly Se Tak Směrem Ke Komercializaci Systému HAPS
- [New Launch] Kai Tak Bay to Offer 100 Units via Price List on Saturday, with Net Selling Prices Starting at HK$5.6 Million
- [New Launch] LOHAS Park’s Kai Tak Bay series has sold over 1,150 units, generating proceeds exceeding HK$10 billion.
- BofA Securities Maintains Takeda Pharmaceutical(TAK.US) With Buy Rating, Maintains Target Price $44.21
- BofA Securities Maintains Takeda Pharmaceutical(TAK.US) With Buy Rating
- Roadshow (00062.HK) and Sun Hung Kai Properties (00016.HK) have jointly submitted a bid for the Kai Tak Smart Green Mass Transit System.
- BofA Securities Maintains Takeda Pharmaceutical(TAK.US) With Buy Rating, Announces Target Price $42.65
- BofA Securities Maintains Takeda Pharmaceutical(TAK.US) With Buy Rating, Raises Target Price to $37.37 正面
- KING INTL INV: Form of proxy for the Annual General Meeting to be held at 12:00 p.m., Room 3302, 33/F, West Tower, Shun Tak Centre, 200 Connaught Road Central, HongKong on Friday, 4 September 2026.
- TD Cowen Maintains Takeda Pharmaceutical(TAK.US) With Buy Rating, Maintains Target Price $21
- HCK: Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DATO' DIONG TAK CHONG @ TIONG TAK CHONG
- World: Narumiya International accelerates its expansion in the Hong Kong market, with its kids' brand "petit main" opening consecutively at Sogo Causeway Bay and Kai Tak stores. 正面
- TD Cowen Maintains Takeda Pharmaceutical(TAK.US) With Buy Rating, Raises Target Price to $21 正面
暂无评论——快来第一个聊聊 TAK。
登录后参与讨论。